Electromagnetic field at extremely low frequencies plays a significant role in the physiological function of human tissues and systems. It is shown that electromagnetic field inhibits production of reactive oxygen species which are involved in heart injury triggered by oxidative stress. We hypothesize that low frequency electromagnetic field protects function of cardiac cells from ischemia–reperfusion injury. Human cardiac myocytes, endothelial cells, and cardiac fibroblast underwent ischemia–reperfusion conditions in the presence or in the absence of low frequency electromagnetic field. LDH and MMP-2 activities (as markers of cell injury), and cell metabolic activity (by fluorescein diacetate staining) were measured to determine the protective role of low frequency electromagnetic field. Our data showed that short courses of low frequency electromagnetic field protect cardiac cells from cellular damage and preserve their metabolic activity during ischemia–reperfusion. This study demonstrates the possibility to use of low frequency electromagnetic field as strategy for the prevention or therapy of ischemia–reperfusion injury.
Impact statement
In our study, we showed that LF-EMF may be protective for heart during ischemia–reperfusion (I/R). Following is the short description of the main findings: (a) the response to the I/R injury was different for endothelial cells, fibroblasts, and cardiomyocytes; (b) I/R decreases MMP-2 activity in cardiac myocytes and fibroblasts; (c) I/R increases MMP-2 activity in endothelial cells; (d) LF-EMF reverses these changes; (e) LF-EMF protects cells from injury and preserves their metabolic activity.
PollmanMJHallJLGibbonsGH.Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury influence of redox state and cell phenotype. Circ Res1999;
84:113–21
3.
ByrneJAGrieveDJCaveACShahAM.Oxidative stress and heart failure. Arch Mal Coeur Vaiss2003;
96:214–21
4.
MaxwellSRJLipGYH.Free radicals and antioxidants in cardiovascular disease. Br J Clin Pharmacol1997;
44:307–17
5.
TakahashiSBarryACFactorSM.Collagen degradation in ischaemic rat hearts. Biochem J1990;
265:233–41
6.
CadeteVJJSawickaJJaswalJSLopaschukGDSchulzRSzczesna-CordaryDSawickiG.Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2. FEBS J2012;
279:2444–54
7.
AliMAMFanXSchulzR.Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease. Trends Cardiovasc Med2011;
21:112–8
8.
AliMAMChowAKKandasamyADFanXWestLJCrawfordBDSimmenTSchulzR.Mechanisms of cytosolic targeting of matrix metalloproteinase-2. J Cell Physiol2012;
227:3397–404
9.
SpinaleFGCokerMLThomasCVWalkerJDMukherjeeRHebbarL.Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res1998;
82:482–95
10.
BendeckMPZempoNClowesAWGalardyREReidyMA.Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res1994;
75:539–45
11.
CheungPYSawickiGSalasEEtchesPCSchulzRRadomskiMW.The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med2000;
28:2584–90
12.
ChevionMLeibowitzSAyeNNNovogrodskyOSingerAAvizemerOBulvikBKonijnAMBerenshteinE.Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin. J Mol Cell Cardiol2008;
45:839–45
13.
JaniMTordaiHTrexlerMBányaiLPatthyL.Hydroxamate-based peptide inhibitors of matrix metalloprotease 2. Biochimie2005;
87:385–92
14.
LöffekSSchillingOFranzkeC-W.Series ‘matrix metalloproteinases in lung health and disease’: biological role of matrix metalloproteinases: a critical balance. Eur Respir J2011;
38:191–208
15.
FunkRHWMonseesTOzkucurN.Electromagnetic effects – from cell biology to medicine. Prog Histochem Cytochem2009;
43:177–264
16.
CossarizzaAAngioniSPetragliaFGenazzaniARMontiDCapriMBersaniFCadossiRFranceschiC.Exposure to low frequency pulsed electromagnetic fields increases interleukin-1 and interleukin-6 production by human peripheral blood mononuclear cells. Exp Cell Res1993;
204:385–7
17.
de GirolamoLStancoDGallieraEViganòMColombiniASettiSVianelloECorsi RomanelliMMSansoneV.Low frequency pulsed electromagnetic field affects proliferation, tissue-specific gene expression, and cytokines release of human tendon cells. Cell Biochem Biophys2013;
66:697–708
18.
BialyDWawrzynskaMBil-LulaIKrzywonos-ZawadzkaAWozniakMCadeteVJSawickiG.Low frequency electromagnetic field conditioning protects against I/R injury and contractile dysfunction in the isolated rat heart. Biomed Res Int2015;
2015:396593
19.
HeussenCDowdleEB.Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem1980;
102:196–202
20.
RandollUGFunkRHW.Rückenschmerz aus dem Blickwinkel neuer Physik und Zellbiologie sowie Behandlung mit der matrix-rhytmus-therapie. Säule Gesunder Rück Besser Leben2004;
14:62–7
21.
GoracaACiejkaEPiechotaA.Effects of extremely low frequency magnetic field on the parameters of oxidative stress in heart. J Physiol Pharmacol2010;
61:333–8
22.
FunkRHWMonseesTK.Effects of electromagnetic fields on cells: physiological and therapeutical approaches and molecular mechanisms of interaction. A review. Cells Tissues Organs2006;
182:59–78
23.
MacklisRM.Magnetic healing, quackery, and the debate about the health effects of electromagnetic fields. Ann Intern Med1993;
118:376–83
24.
RaggiFVallesiGRufiniSGizziSErcolaniERossiR.ELF magnetic therapy and oxidative balance. Electromagn Biol Med2008;
27:325–39
25.
MaSZhangZYiFWangYZhangXLiXYuan Y, Cao F.Protective effects of low-frequency magnetic fields on cardiomyocytes from ischemia reperfusion injury via ROS and NO/ONOO. Oxid Med Cell Longev2013;
2013:529173
26.
PillaAA.Low-intensity electromagnetic and mechanical modulation of bone growth and repair: are they equivalent?J Orthop Sci2002;
7:420–8
27.
HartigMJoosUWiesmannHP.Capacitively coupled electric fields accelerate proliferation of osteoblast-like primary cells and increase bone extracellular matrix formation in vitro. Eur Biophys J2000;
29:499–506
28.
XinMOlsonENBassel-DubyR.Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol2013;
14:529–41
FaloneSMirabilioACarboneMCZimmittiVDi LoretoSMariggiòMAMancinelliRDi IlioCAmicarelliF.Chronic exposure to 50Hz magnetic fields causes a significant weakening of antioxidant defence systems in aged rat brain. Int J Biochem Cell Biol2008;
40:2762–70
33.
StoweDFCamaraAKS.Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal2009;
11:1373–414
34.
KlimovaTChandelNS.Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ2008;
15:660–6
35.
GolbachLAPortelliLASavelkoulHFJTerwelSRKusterNde VriesRBMVerburg-van KemenadeBM.Calcium homeostasis and low-frequency magnetic and electric field exposure: a systematic review and meta-analysis of in vitro studies. Environ Int2016;
92–93:695–706
36.
VianaleGRealeMAmerioPStefanachiMDi LuzioSMuraroR.Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production. Br J Dermatol2008;
158:1189–96
37.
DoroszkoAPolewiczDCadeteVJJSawickaJJonesMSzczesna-CordaryDCheungPYSawickiG.Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction. Shock2010;
34:592–600
38.
WangWSchulzeCJSuarez-PinzonWLDyckJRBSawickiGSchulzR.Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation2002;
106:1543–9
39.
SiwikDAChangDLColucciWS.Interleukin 1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res2000;
86:1259–65
40.
StamenkovicI.Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol2003;
200:448–64
41.
HooperNM.Families of zinc metalloproteases. FEBS Lett1994;
354:1–6
42.
LinH-BCadeteVJJSraBSawickaJChenZBekarLKCayabyabFSawickiG.Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injury. Biomed Res Int2014;
2014:810371
43.
CadeteVJJSawickaJBekarLKSawickiG.Combined subthreshold dose inhibition of myosin light chain phosphorylation and MMP-2 activity provides cardioprotection from ischaemic/reperfusion injury in isolated rat heart. Br J Pharmacol2013;
170:380–90
44.
LiPFDietzRvon HarsdorfR.Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts. FEBS Lett1999;
448:206–10
45.
Ben-YosefYLahatNShapiroSBittermanHMillerA.Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res2002;
90:784–91
